Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue

Abstract

Introduction: Hepatitis C virus (HCV) infection is a worldwide problem and hepatitis, which is its natural unfavourable course, is still a challenge for hepatologist. At present, standards of treatment are changing from combined therapy with interferon alpha (IFN-α) and ribavirin to new antiviral drugs. The current classification divides interferon induced thyroid diseases (IITD) into two groups: autoimmune (Hashimoto disease, Graves disease, positive antithyroid autoantibodies in euthyroid patients) and non-autoimmune (destructive thyroiditis, non-autoimmune hypothyroidism). A common complication of cytokine therapy is the induction of antithyroid autoantibodies de novo without thyroid dysfunction. During therapeutic regimens combined with ribavirin, destructive thyroiditis with typical biphasic course is more common than in IFN-α monotherapy. Clinically, overt pathologies often have discrete symptoms, which cause diagnostic and therapeutic dilemmas. Aims: The aim of this study was to estimate IITD occurrence, to find risk factors for IITD development. Material and methods: The study group consisted of 66 patients treated for HCV infection. Before and during antiviral therapy, hormonal (TSH, fT4, fT3), immunological (thyroid autoantibodies), ultrasonographic and genetic (HLA-A2) parameters were evaluated. Results: Hormonal disturbances were detected in 24.2% of patients; however, 43.9% of patients had positive thyroid autoantibodies (de novo) without hormonal imbalance. Multivariate analysis revealed the following: female sex, elevated TSH level, occurrence of anti-TPO autoantibodies (TPO-Ab), and increased blood velocity in thyroid arteries are risk factors for IITD development. In conclusion: Thyroid disorders are common during IFN-α therapy. Previous epidemiological data seem to be underestimated. Important risk factors for IITD development are: female sex, elevated serum TSH concentration (≥2.5 μU/mL), positive TPO-Ab and increased blood velocity in thyroid arteries.

Authors and Affiliations

Łukasz Obołończyk, Małgorzata Siekierska-Hellmann, Piotr Wiśniewski, Anna Lewczuk, Monika Berendt-Obołończyk, Zofia Michalska, Danuta Radowska, Grażyna Moszkowska, Agnieszka Bianek-Bodzak, Krzysztof Sworczak

Keywords

Related Articles

Theta rhythm recorded in the hippocampal formation in vitro

Theta rhythm is the best synchronized EEG activity that can be recorded in the mammalian brain.Hippocampal formation (HPC) is considered to be the main structure involved in the generationof this activity. Numerous data...

Wnt signaling pathway – its role in regulation of cell metabolism

The Wnt signaling pathway plays an important role in morphogenesis, differentiation, cell survival and proliferation. Wnt activators are secreted proteins that work in an auto-, para- and endocrine manner and their synth...

Limfocyty Th17 w zakażeniach bakteryjnych

Komórki Th17 są niedawno odkrytą subpopulacją pomocniczych limfocytów T CD4+. Wykazano, że komórki te przyczyniają się do uszkodzeń w przebiegu licznych chorób tła immunologicznego oraz odgrywają istotną rolę w odpornośc...

Negatywna regulacja sygnalizacji receptorów Toll-podobnych

Mechanizm odporności wrodzonej działa w oparciu o receptory PRR – rozpoznające tzw. wzorce molekularne związane z patogenami – PAMPs. Wśród receptorów PRR wyróżnia się: receptory Toll-podobne (TLR). W wyniku kontaktu z p...

Identification of the genes expression profile associated with the ex vivo resistance to etoposide in childhood acute leukemias

Introduction: Drug resistance and the gene expression profiles might discriminate the therapy outcome, and indicate the subgroup of patients with poor prognosis. In this study we analyzed the gene expression profile in...

Download PDF file
  • EP ID EP223268
  • DOI 10.5604/01.3001.0010.4782
  • Views 163
  • Downloads 0

How To Cite

Łukasz Obołończyk, Małgorzata Siekierska-Hellmann, Piotr Wiśniewski, Anna Lewczuk, Monika Berendt-Obołończyk, Zofia Michalska, Danuta Radowska, Grażyna Moszkowska, Agnieszka Bianek-Bodzak, Krzysztof Sworczak (2017). Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study. Advances in Hygiene and Experimental Medicine, 71(), 842-849. https://europub.co.uk/articles/-A-223268